Back to results
US 2021/0228533 A1Published application
Pharmaceutical composition, methods for treating and uses thereof
AssigneeBoehringer Ingelheim International GmbH
InventorsMaximilian von EYNATTEN, Uli Christian BROEDL, Hans-Juergen WOERLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating or preventing chronic kidney disease and cardiovascular disease in patients with chronic kidney disease comprising administering empagliflozin to the patient.
Claims17
A method of treating, reducing the risk of or slowing the progression of chronic kidney disease in a patient with chronic kidney disease, said method comprising administering empagliflozin to the patient.
Dependencies are inferred from the claim text.